Fundraising Fox

Dispatch Biotherapeutics

1 known investors

dispatchbio.com ↗

Dispatch Bio develops a universal immunotherapy treatment for solid tumors, combining engineered immunotherapy with a tumor-specific virus to improve cancer treatment outcomes.

BiotechDeep TechMedical Devices

Founders & leadership

SO
Sabah OneyChief Executive Officer
LJ
Lex JohnsonCo-Founder and Chief Platform Officer
RL
Ray LiuCo-founder and Head of Synthetic Biology

Investors · 1

ARCH Venture PartnersChicago

In the news